2014Unpublished venueRequires access

Actinic Keratosis and Bowen's Disease

Sasha N. Jenkins, Maren Speck, Suephy C. Chen

Open publisher page 0 citations

Abstract

Actinic keratosis and Bowen's diseases are both precursors to invasive squamous cell carcinoma. The major risk factor for both is ultraviolent radiation. The risk of progression from actinic keratosis into invasive squamous cell carcinoma ranges from less than 1% to 16%, while the risk for Bowen's disease is 3–5%. There are multiple treatment modalities for these precancerous lesions, but there is no standard of care. Thus, treatment should be directed based upon the location, size, age group, immune status, cost, and patient preference.

About this research paper

What this paper is about

Actinic keratosis and Bowen's diseases are both precursors to invasive squamous cell carcinoma. The major risk factor for both is ultraviolent radiation. The risk of progression from actinic keratosis into invasive squamous cell carcinoma ranges from less than 1% to 16%, while the risk for Bowen's disease is 3–5%. There are multiple treatment modalities for these precancerous lesions, but there is no standard of care. Thus, treatment should be directed based upon the location, size, age group, immune status, cost, and patient preference.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Actinic keratosis and Bowen's diseases are both precursors to invasive squamous cell carcinoma. The major risk factor for both is ultraviolent radiation. The risk of progression from actinic keratosis into invasive squamous cell carcinoma ranges from less than 1% to 16%, while the risk for Bowen's disease is 3–5%. There are multiple treatment modalities for these precancerous lesions, but there is no standard of care. Thus, treatment should be directed based upon the location, size, age group, immune status, cost, and patient preference.

Key concepts: Actinic keratosis, Bowen's disease, Dermatology, Medicine, Basal cell, Keratosis, Disease, Risk factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Actinic Keratosis and Bowen's Disease — Research Paper | ScholarLens